Second-Line Therapy after Radical Prostatectomy Failure: For Whom? When? How?

European Urology

Volumn 51, Issue 5, 2007, Pages 1155-1157

  Aus, Gunnar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ALGORITHM; CANCER RADIOTHERAPY; CANCER RELAPSE; EDITORIAL; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING;

HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 33947272998     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.01.069     Document Type: Editorial

References (9)

1. Chun F.K., Graefen M., Zacharias M., et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 24 (2006) 273-280
2. Simmons M.N., Stephenson A.J., and Klein E.A. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 51 (2007) 1175-1184
3. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1998) 1591-1597
4. Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer mortality following biochemical recurrence after radical prostatectomy. JAMA 294 (2005) 433-439
5. Cowen M.E., Halasyamani L.K., and Kattan M.V. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 175 (2006) 99-103
6. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291 (2004) 1325-1332
7. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
8. Dotan Z.A., Bianco Jr. F.J., Rabbani F., et al. Pattern of prostate specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol 23 (2005) 1962-1968
9. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578